Skip to content
Toggle main navigation
Immunize Oregon logo
Immunize Oregon logo
  • Welcome
    • Immunize Oregon
  • Vaxx Clinic
  • Events
  • Groups
  • News
  • Opportunities
  • Lobby
    Log in
    Request to join
    Select an available language
    EN

    News

    All
    3-D printing
    Abdul Latif Jameel Poverty Action Lab (J-PAL)
    Abdul Latif Jameel Water and Food Systems Lab (J-WAFS)
    Administration
    Aeronautical and astronautical engineering
    Africa
    Agriculture
    Algorithms
    Alumni/ae
    Alzheimer's
    Anesthesia
    Anthropology
    Antibiotics
    Artificial intelligence
    Asia
    See all

    Highlighted News

    Results (30)

    New formulation helps RNA vaccines withstand high temperatures

    New formulation helps RNA vaccines withstand high temperatures

    RNA vaccines, which have been proven effective against Covid-19, are now being developed for many other diseases, including cancer. One of the drawbacks to these vaccines is that they require ultracold storage, but researchers from MIT have found a promising way to overcome that limitation.With help from an AI algorithm, the researchers tweaked the formulation surrounding the lipid nanoparticles t
    September 28, 2026
    Particles that enhance mRNA delivery could reduce vaccine dosage and costs

    Particles that enhance mRNA delivery could reduce vaccine dosage and costs

    A new delivery particle developed at MIT could make mRNA vaccines more effective and potentially lower the cost per vaccine dose.In studies in mice, the researchers showed that an mRNA influenza vaccine delivered with their new lipid nanoparticle could generate the same immune response as mRNA delivered by nanoparticles made with FDA-approved materials, but at around 1/100 the dose.“One of the cha
    November 7, 2025
    MIT researchers develop AI tool to improve flu vaccine strain selection

    MIT researchers develop AI tool to improve flu vaccine strain selection

    Every year, global health experts are faced with a high-stakes decision: Which influenza strains should go into the next seasonal vaccine? The choice must be made months in advance, long before flu season even begins, and it can often feel like a race against the clock. If the selected strains match those that circulate, the vaccine will likely be highly effective. But if the prediction is off, pr
    August 28, 2025
    Supercharged vaccine could offer strong protection with just one dose

    Supercharged vaccine could offer strong protection with just one dose

    Researchers at MIT and the Scripps Research Institute have shown that they can generate a strong immune response to HIV with just one vaccine dose, by adding two powerful adjuvants — materials that help stimulate the immune system.In a study of mice, the researchers showed that this approach produced a much wider diversity of antibodies against an HIV antigen, compared to the vaccine given on its
    June 18, 2025
    A new vaccine approach could help combat future coronavirus pandemics

    A new vaccine approach could help combat future coronavirus pandemics

    A new experimental vaccine developed by researchers at MIT and Caltech could offer protection against emerging variants of SARS-CoV-2, as well as related coronaviruses, known as sarbecoviruses, that could spill over from animals to humans.In addition to SARS-CoV-2, the virus that causes COVID-19, sarbecoviruses — a subgenus of coronaviruses — include the virus that led to the outbreak of the origi
    January 23, 2025
    Researchers study differences in attitudes toward Covid-19 vaccines between women and men in Africa

    Researchers study differences in attitudes toward Covid-19 vaccines between women and men in Africa

    While many studies over the past several years have examined people’s access to and attitudes toward Covid-19 vaccines, few studies in sub-Saharan Africa have looked at whether there were differences in vaccination rates and intention between men and women. In a new study appearing in the journal Frontiers in Global Women’s Health, researchers found that while women and men self-reported similar C
    July 10, 2024
    MIT scientists use a new type of nanoparticle to make vaccines more powerful

    MIT scientists use a new type of nanoparticle to make vaccines more powerful

    Many vaccines, including vaccines for hepatitis B and whooping cough, consist of fragments of viral or bacterial proteins. These vaccines often include other molecules called adjuvants, which help to boost the immune system’s response to the protein.Most of these adjuvants consist of aluminum salts or other molecules that provoke a nonspecific immune response. A team of MIT researchers has now sho
    March 6, 2024
    Noubar Afeyan PhD ’87 to deliver MIT’s 2024 Commencement address

    Noubar Afeyan PhD ’87 to deliver MIT’s 2024 Commencement address

    Noubar Afeyan PhD ’87, an inventor and parallel entrepreneur with a penchant for bold ideas, will deliver the address at the OneMIT Commencement Ceremony on Thursday, May 30.Afeyan is the founder and CEO of the venture creation company Flagship Pioneering, which founds companies that build biotechnology platforms to transform human health and sustainability. Since its founding in 2000, the company
    February 1, 2024
    DNA particles that mimic viruses hold promise as vaccines

    DNA particles that mimic viruses hold promise as vaccines

    Using a virus-like delivery particle made from DNA, researchers from MIT and the Ragon Institute of MGH, MIT, and Harvard have created a vaccine that can induce a strong antibody response against SARS-CoV-2.The vaccine, which has been tested in mice, consists of a DNA scaffold that carries many copies of a viral antigen. This type of vaccine, known as a particulate vaccine, mimics the structure of
    January 30, 2024
    MIT engineers design more powerful RNA vaccines

    MIT engineers design more powerful RNA vaccines

    RNA vaccines against Covid-19 have proven effective at reducing the severity of disease. However, a team of researchers at MIT is working on making them even better. By tweaking the design of the vaccines, the researchers showed that they could generate Covid-19 RNA vaccines that produce a stronger immune response, at a lower dose, in mice.Adjuvants are molecules commonly used to increase the immu
    September 7, 2023
    Chemists’ technique reveals whether antibodies neutralize SARS-CoV-2

    Chemists’ technique reveals whether antibodies neutralize SARS-CoV-2

    Antibodies that can disarm a virus, known as neutralizing antibodies, are key to the body’s ability to fight off infection. MIT chemists have come up with a new way to identify these neutralizing antibodies in a blood sample, by analyzing how antibodies interact with sugar molecules found on the surface of a viral protein.The new test could help to reveal whether someone has neutralizing antibodie
    May 10, 2023
    Championing health workers to lead vaccination efforts in Uganda

    Championing health workers to lead vaccination efforts in Uganda

    Uganda reported its first case of Covid-19 on March 21, 2020. Almost a year later, the first batch of vaccines to protect against the spread of the disease arrived in the country.As people began receiving their injections in the ensuing months, researchers from the MIT Governance Lab (MIT GOV/LAB) and Makerere University’s School of Public Health in Uganda wanted to understand what was motivating
    April 20, 2023
    Creating a versatile vaccine to take on Covid-19 in its many guises

    Creating a versatile vaccine to take on Covid-19 in its many guises

    One of the 12 labors of Hercules, according to ancient lore, was to destroy a nine-headed monster called the Hydra. The challenge was that when Hercules used his sword to chop off one of the monster’s heads, two would grow back in its place. He therefore needed an additional weapon, a torch, to vanquish his foe.There are parallels between this legend and our three-years-and-counting battle with SA
    March 9, 2023
    SMART researchers develop quick test to determine immunity against Covid-19

    SMART researchers develop quick test to determine immunity against Covid-19

    A team of scientists from the Singapore-MIT Alliance for Research and Technology (SMART), MIT’s research enterprise in Singapore, and Nanyang Technological University, Singapore (NTU Singapore) has developed a quick test kit that can tell if a person has immunity against Covid-19 and its variants, based on the antibodies detected in a blood sample.Unlike ART test kits — which look for the presence
    September 30, 2022
    Microparticles could be used to deliver “self-boosting” vaccines

    Microparticles could be used to deliver “self-boosting” vaccines

    Most vaccines, from measles to Covid-19, require a series of multiple shots before the recipient is considered fully vaccinated. To make that easier to achieve, MIT researchers have developed microparticles that can be tuned to deliver their payload at different time points, which could be used to create “self-boosting” vaccines.In a new study, the researchers describe how these particles degrade
    July 13, 2022
    Robert Langer wins BBVA Foundation Frontiers of Knowledge Award

    Robert Langer wins BBVA Foundation Frontiers of Knowledge Award

    Robert Langer, the David H. Koch (1962) Institute Professor at MIT, received yesterday the 2022 BBVA Foundation Frontiers of Knowledge Award in Biology and Biomedicine in recognition of his contributions to messenger (mRNA) therapeutics and delivery technology, which enabled the rapid development of SARS-CoV-2 vaccines.Langer shares the award with Katalin Karikó and Drew Weissman, both of the Univ
    June 17, 2022
    3 Questions: Daniel Anderson on the progress of mRNA vaccines

    3 Questions: Daniel Anderson on the progress of mRNA vaccines

    Two mRNA vaccines, which received emergency authorization in late 2020, have proven critical in the fight against Covid-19. These vaccines, the first of their kind, were the culmination of decades of research on RNA. Delivered as strands of mRNA that encode a viral protein, the vaccines enter cells and begin producing proteins, allowing the immune system to recognize the virus if encountered later
    May 13, 2022
    A stark warning about threats to truth, science, and democracy

    A stark warning about threats to truth, science, and democracy

    Renowned newspaper editor Martin Baron issued a grim warning to an MIT audience on Thursday, stating that the avalanche of lies and falsehoods permeating the media people consume today constitutes a direct threat to U.S. democracy and civil society.“The path we are on today is an invitation to ruin,” said Baron, while delivering MIT’s annual spring Compton Lecture.Baron, who served as executive ed
    April 25, 2022
    Advocating for vaccine equity

    Advocating for vaccine equity

    When Digbijay Mahat arrived at MIT in 2017 to begin his postdoctoral studies, he had one very clear goal: to become an expert in cancer research and diagnostics so he could improve health care in Nepal, where he was born. In 2020, when the Covid-19 pandemic laid bare additional discrepancies in resource equity around the world, his goal did not waiver. But it did expand to fill a more immediate ne
    March 18, 2022
    A possible new Covid-19 vaccine could be accessible for more of the world

    A possible new Covid-19 vaccine could be accessible for more of the world

    While many people in wealthier countries have been vaccinated against Covid-19, there is still a need for vaccination in much of the world. A new vaccine developed at MIT and Beth Israel Deaconess Medical Center may aid in those efforts, offering an inexpensive, easy-to-store, and effective alternative to RNA vaccines.In a new paper, the researchers report that the vaccine, which comprises fragmen
    March 16, 2022
    Contact
    Immunize Oregon
    PO BOX 4391, Portland, Oregon 97208

    United States

    Coordinator@immunizeor.org
    Links
    • Immunize Oregon Website
    Cookies
    Reselect cookie settings
    Community engagement platform by Hivebrite.